Arthropod venom peptides (from scorpions, spiders, bees, wasps) combined with nanodelivery systems show anticancer potential through membrane disruption, apoptosis, angiogenesis inhibition, and immune modulation.
4 animal sourcesScorpion, spider, bee, and wasp venoms each contribute unique anticancer peptides with distinct mechanisms
What the researchers found
Arthropod venom peptides exhibit multi-mechanism anticancer activity (membrane disruption, apoptosis, anti-angiogenesis, immune modulation), with nanodelivery systems overcoming stability, toxicity, and targeting limitations.
Why it matters
Cancer treatment needs new approaches. Venom peptides offer multi-mechanism killing that could overcome drug resistance, and nanotechnology makes them clinically practical.
How the study worked
Comprehensive review of arthropod venom peptide anticancer mechanisms and nanotechnology-based delivery platforms, covering literature from 2000-2025.
What this study cannot tell us
Most evidence preclinical. Venom peptide toxicity management remains challenging. Manufacturing at scale is complex.
How to read the evidence
Comprehensive review of preclinical literature spanning 25 years. Rich peptide pipeline but limited clinical translation to date.
When this study was published
Published in 2025.
The bigger picture
The convergence of venomics and nanomedicine represents a new therapeutic paradigm where nature provides the weapons and nanotechnology provides the targeting system.
Questions still open
- Which venom peptide-nanoparticle combination is closest to clinical trials?
- Can venom peptides overcome multidrug resistance in cancer?
- Are there synergies between venom peptides and immune checkpoint drugs?
Common questions
Can venom peptides treat cancer?
Which venom is most promising for cancer?
Read the original research
Arthropod venom peptides: Pioneering nanotechnology in cancer treatment and drug delivery.
Cancer pathogenesis and therapy, 4(2), 81-97
Citation
Ghodeif, Sara K; El-Fahla, Nadia A; Abdel-Rahman, Mohamed A; El-Shenawy, Nahla S. (2026). Arthropod venom peptides: Pioneering nanotechnology in cancer treatment and drug delivery.. Cancer pathogenesis and therapy, 4(2), 81-97. https://doi.org/10.1016/j.cpt.2025.03.005